Haleon PLC ( (GB:HLN) ) has provided an update.
Haleon PLC announced that Pfizer Inc. has sold its entire residual interest in the company, amounting to 661,709,764 ordinary shares. This transaction, which included a secondary offering and an off-market sale, marks Pfizer’s complete exit from its stake in Haleon, potentially impacting the company’s shareholder structure and market dynamics.
More about Haleon PLC
Haleon PLC is a UK-based company operating in the healthcare industry, primarily focusing on consumer health products. The company offers a range of products aimed at improving everyday health and wellness for consumers worldwide.
YTD Price Performance: 4.40%
Average Trading Volume: 25,029,369
Technical Sentiment Consensus Rating: Sell
Current Market Cap: £35.41B
For detailed information about HLN stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com